APA (7th ed.) Citation

AF, A., F, M., M, O., MO, A., M, A. R., H, S., . . . MA, Y. (2026). Real-world use of emapalumab in hemophagocytic lymphohistiocytosis: A scoping review of published evidence. Frontiers in pharmacology, 17, 1749084. https://doi.org/10.3389/fphar.2026.1749084

Chicago Style (17th ed.) Citation

AF, Al-Mashdali, Mohamed F, Osman M, Abdelraof MO, Al Rasheed M, Salama H, Mohamed SF, and Yassin MA. "Real-world Use of Emapalumab in Hemophagocytic Lymphohistiocytosis: A Scoping Review of Published Evidence." Frontiers in Pharmacology 17 (2026): 1749084. https://doi.org/10.3389/fphar.2026.1749084.

MLA (9th ed.) Citation

AF, Al-Mashdali, et al. "Real-world Use of Emapalumab in Hemophagocytic Lymphohistiocytosis: A Scoping Review of Published Evidence." Frontiers in Pharmacology, vol. 17, 2026, p. 1749084, https://doi.org/10.3389/fphar.2026.1749084.

Warning: These citations may not always be 100% accurate.